Carb-X

Events

  • Innovative Medicines Initiative (IMI) ENABLE Annual Meeting

    VIRTUAL EVENT

    Antimicrobial resistance (AMR) is a major public health threat. Infections caused by resistant bacteria are increasing and causing Europe to face soaring costs both in terms of lives and public health expenditure. Despite the strong need for new antimicrobials, very few new, effective antibiotics have been brought to the market in the last decades. The […]

  • 5th Microbiome Movement – Drug Development Summit Europe 2021

    Participants include CARB-X funded companies Eligo Bioscience and Seres Therapeutics. As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target […]

  • BSAC/GARDP Antimicrobial Chemotherapy Virtual Conference 2021

    VIRTUAL EVENT

    Jointly organised by the BSAC and GARDP. For 2021, the conference collaborators are the Helmholtz Institute for Pharmaceutical Sciences (HIPS), the German Center for Infection Research (DZIF) and the International Research Alliance for Antibiotic Discovery and Development (IRAADD) (a JPIAMR funded network) Click here to learn more. Click here to register.

  • The Bloomsbury SET Conference on Infectious Disease and AMR

    VIRTUAL EVENT

    The Bloomsbury SET is hosting its first virtual conference focused on knowledge exchange and infectious disease during the 22nd to 26th February 2021. Throughout the week, the Bloomsbury SET and […]

  • Phage Futures Congress

    VIRTUAL EVENT

    Join us at the International Phage Futures Congress in 2021, as we create a virtual stage upon which to initiate all-important discussions & forge partnerships between key stakeholders from all […]

  • BARDA AMR Vaccine Public Workshop: Vaccines against AMR Threats

    VIRTUAL EVENT

    Multi-drug resistant (MDR) organisms are a threat to national security and public health. As rates of antimicrobial resistance (AMR) in pathogens continue to increase new therapeutics and vaccines are essential […]